Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components

Απλή σελίδα τεκμηρίου
dc.contributor.authorIoachim, E.en
dc.contributor.authorMichael, M. C.en
dc.contributor.authorSalmas, M.en
dc.contributor.authorDamala, K.en
dc.contributor.authorTsanou, E.en
dc.contributor.authorMichael, M. M.en
dc.contributor.authorMalamou-Mitsi, V.en
dc.contributor.authorStavropoulos, N. E.en
dc.date.accessioned2015-11-24T19:15:52Z
dc.date.available2015-11-24T19:15:52Z
dc.identifier.issn1471-2407-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/21576
dc.rightsDefault Licence-
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectAntigens, CD34/metabolismen
dc.subjectCarcinoma/*metabolism/pathologyen
dc.subjectCell Counten
dc.subjectDisease Progressionen
dc.subjectExtracellular Matrix Proteins/*metabolismen
dc.subjectFemaleen
dc.subjectFibronectins/metabolismen
dc.subjectFollow-Up Studiesen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectNeovascularization, Pathologic/*metabolismen
dc.subjectPrognosisen
dc.subjectRetrospective Studiesen
dc.subjectTenascin/metabolismen
dc.subjectThrombospondin 1/*metabolismen
dc.subjectTumor Suppressor Protein p53/*metabolismen
dc.subjectUrinary Bladder Neoplasms/*metabolism/pathologyen
dc.subjectUrothelium/*metabolism/pathologyen
dc.subjectVascular Endothelial Growth Factor A/metabolismen
dc.titleThrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix componentsen
heal.abstractBACKGROUND: Thrombospondin-1 (TSP-1) is an extracellular matrix component glycoprotein, which is known to be a potent inhibitor of angiogenesis and may be important in cancer invasiveness. We examined the TSP-1 expression in correlation with conventional clinicopathological parameters to clarify its prognostic significance in bladder cancer. In addition, the possible correlation of TSP-1 expression with microvessel count, VEGF expression, p53 expression as well as with the expression of the extracellular matrix components was studied to explore its implication in vascularization and tumour stroma remodeling. METHODS: The immunohistochemical expression of TSP-1 in tumour cells and in the tumour stroma was studied in 148 formalin-fixed paraffin-embedded urothelial cell carcinoma tissue samples. RESULTS: TSP-1 was detected in perivascular tissue, at the epithelial-stromal junction, in the stroma and in tumour cells in the majority of the cases. In tumour cells, low TSP-1 expression was observed in 43% of the cases, moderate and high in 7%, while 50% showed absence of TSP expression. A higher TSP-1 immunoreactivity in well and moderately differentiated tumours compared to poorly differentiated was noted. PT1 tumours showed decreased TSP-1 expression in comparison to pTa and pT2-4 tumours. Increased tumour cell TSP-1 expression was related to increased microvessel density. In the tumour stroma, 37% of the cases showed small amount of TSP-1 expression, 7.5% moderate and high, while 55% of the cases showed absence of TSP-1 stromal immunoreactivity. Stromal TSP-1 expression was inversely correlated with tumour stage and tumour size. This expression was also positively correlated with microvessel density, VEGF expression and extracellular matrix components tenascin and fibronectin. Using univariate and multivariate analysis we didn't find any significant correlation of TSP-1 expression in superficial tumours in both tumour cells and tumour stroma in terns of the risk of recurrence and disease progression CONCLUSION: Our data suggest that both tumour and stromal TSP-1 expression may play a role in tumour aggressiveness and angiogenesis. In addition, the correlation of stromal TSP-1 expression with extracellular matrix components fibronectin and tenascin indicate its possible implication in tumour stroma remodeling.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1186/1471-2407-6-140-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/16732887-
heal.identifier.secondaryhttp://www.biomedcentral.com/1471-2407/6/140-
heal.journalNameBMC Canceren
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2006-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Πρωτότυπος φάκελος/πακέτο

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
Malamou-Mitsi-2006-thrombospondin I expression.pdf
Μέγεθος:
320.01 KB
Μορφότυπο:
Adobe Portable Document Format
Κατεβάστε

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ